|
1
|
Döhner H, Weisdorf DJ and Bloomfield CD:
Acute myeloid leukemia. N Engl J Med. 373:1136–1152. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Polednak AP: Recent improvement in
completeness of incidence data on acute myeloid leukemia in US
cancer registries. J Registry Manag. 41:77–84. 2014.PubMed/NCBI
|
|
3
|
Tawfik B, Pardee TS, Isom S, Sliesoraitis
S, Winter A, Lawrence J, Powell BL and Klepin HD: Comorbidity, age,
and mortality among adults treated intensively for acute myeloid
leukemia (AML). J Geriatr Oncol. 7:24–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Almeida AM and Ramos F: Acute myeloid
leukemia in the older adults. Leuk Res Rep. 6:1–7. 2016.PubMed/NCBI
|
|
5
|
Percival ME, Tao L, Medeiros BC and Clarke
CA: Improvements in the early death rate among 9,380 patients with
acute myeloid leukemia after initial therapy: A SEER database
analysis. Cancer. 121:2004–2012. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhatnagar B and Garzon R: The use of
molecular genetics to refine prognosis in acute myeloid leukemia.
Curr Hematol Malig Rep. 9:148–157. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stölzel F, Mohr B, Kramer M, Oelschlägel
U, Bochtler T, Berdel WE, Kaufmann M, Baldus CD, Schäfer-Eckart K,
Stuhlmann R, et al: Karyotype complexity and prognosis in acute
myeloid leukemia. Blood Cancer J. 6:e3862016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mrózek K and Bloomfield CD: Chromosome
aberrations, gene mutations and expression changes, and prognosis
in adult acute myeloid leukemia. Hematology Am Soc Hematol Educ
Program. 2006:169–177. 2006. View Article : Google Scholar
|
|
9
|
Papaemmanuil E, Gerstung M, Bullinger L,
Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F,
Bolli N, et al: Genomic classification and prognosis in acute
myeloid leukemia. N Engl J Med. 374:2209–2221. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Byun JM, Kim YJ, Yoon HJ, Kim SY, Kim HJ,
Yoon J, Min YH, Cheong JW, Park J, Lee JH, et al: Cytogenetic
profiles of 2,806 patients with acute myeloid leukemia-a
retrospective multicenter nationwide study. Ann Hematol.
95:1223–1232. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li S, Mason CE and Melnick A: Genetic and
epigenetic heterogeneity in acute myeloid leukemia. Curr Opin Genet
Dev. 36:100–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cancer Genome Atlas Research Network, ;
Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A,
Hoadley K, Triche TJ Jr, Laird PW, et al: Genomic and epigenomic
landscapes of adult de novo acute myeloid leukemia. N Engl J Med.
368:2059–2074. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li S, Garrett-Bakelman FE, Chung SS,
Sanders MA, Hricik T, Rapaport F, Patel J, Dillon R, Vijay P, Brown
AL, et al: Distinct evolution and dynamics of epigenetic and
genetic heterogeneity in acute myeloid leukemia. Nat Med.
22:792–799. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sasca D and Huntly BJ: Independence of
epigenetic and genetic diversity in AML. Nat Med. 22:708–709. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet 15 Spec No. 1:R17–R29. 2006. View Article : Google Scholar
|
|
16
|
Morris KV and Mattick JS: The rise of
regulatory RNA. Nat Rev Genet. 15:423–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goff LA and Rinn JL: Linking RNA biology
to lncRNAs. Genome Res. 25:1456–1465. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ling H, Vincent K, Pichler M, Fodde R,
Berindan-Neagoe I, Slack FJ and Calin GA: Junk DNA and the long
non-coding RNA twist in cancer genetics. Oncogene. 34:5003–5011.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garzon R, Volinia S, Papaioannou D,
Nicolet D, Kohlschmidt J, Yan PS, Mrózek K, Bucci D, Carroll AJ,
Baer MR, et al: Expression and prognostic impact of lncRNAs in
acute myeloid leukemia. Proc Natl Acad Sci USA. 111:18679–18684.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morlando M, Ballarino M and Fatica A: Long
non-coding RNAs: New players in hematopoiesis and leukemia. Front
Med (Lausanne). 2:232015.PubMed/NCBI
|
|
23
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Lian Z, Padden C, Gerstein MB,
Rozowsky J, Snyder M, Gingeras TR, Kapranov P, Weissman SM and
Newburger PE: A myelopoiesis-associated regulatory intergenic
noncoding RNA transcript within the human HOXA cluster. Blood.
113:2526–2534. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xing CY, Hu XQ, Xie FY, Yu ZJ, Li HY,
Bin-Zhou, Wu JB, Tang LY and Gao SM: Long non-coding RNA HOTAIR
modulates c-KIT expression through sponging miR-193a in acute
myeloid leukemia. FEBS Lett. 589:1981–1987. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma L, Bajic VB and Zhang Z: On the
classification of long non-coding RNAs. RNA Biol. 10:925–933. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mattick JS and Rinn JL: Discovery and
annotation of long noncoding RNAs. Nat Struct Mol Biol. 22:5–7.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khorkova O, Myers AJ, Hsiao J and
Wahlestedt C: Natural antisense transcripts. Hum Mol Genet.
23:R54–R63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Katayama S, Tomaru Y, Kasukawa T, Waki K,
Nakanishi M, Nakamura M, Nishida H, Yap CC, Suzuki M, Kawai J, et
al: Antisense transcription in the mammalian transcriptome.
Science. 309:1564–1566. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
ENCODE Project Consortium. An integrated
encyclopedia of DNA elements in the human genome. Nature.
489:57–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Su WY, Xiong H and Fang JY: Natural
antisense transcripts regulate gene expression in an epigenetic
manner. Biochem Biophys Res Commun. 396:177–181. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wight M and Werner A: The functions of
natural antisense transcripts. Essays Biochem. 54:91–101. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ebralidze AK, Guibal FC, Steidl U, Zhang
P, Lee S, Bartholdy B, Jorda MA, Petkova V, Rosenbauer F, Huang G,
et al: PU.1 expression is modulated by the balance of functional
sense and antisense RNAs regulated by a shared cis-regulatory
element. Genes Dev. 22:2085–2092. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun J, Li W, Sun Y, Yu D, Wen X, Wang H,
Cui J, Wang G, Hoffman AR and Hu JF: A novel antisense long
noncoding RNA within the IGF1R gene locus is imprinted in
hematopoietic malignancies. Nucleic Acids Res. 42:9588–9601. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Beltran M, Puig I, Peña C, García JM,
Alvarez AB, Peña R, Bonilla F and de Herreros AG: A natural
antisense transcript regulates Zeb2/Sip1 gene expression during
Snail1-induced epithelial-mesenchymal transition. Genes Dev.
22:756–769. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Arber DA, Orazi A, Hasserjian R, Thiele J,
Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M and Vardiman JW:
The 2016 revision to the World Health Organization classification
of myeloid neoplasms and acute leukemia. Blood. 127:2391–2405.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Metzeler KH, Herold T, Rothenberg-Thurley
M, Amler S, Sauerland MC, Görlich D, Schneider S, Konstandin NP,
Dufour A, Bräundl K, et al: Spectrum and prognostic relevance of
driver gene mutations in acute myeloid leukemia. Blood.
128:686–698. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Grimwade D, Hills RK, Moorman AV, Walker
H, Chatters S, Goldstone AH, Wheatley K, Harrison CJ and Burnett
AK; National Cancer Research Institute Adult Leukaemia Working
Group, : Refinement of cytogenetic classification in acute myeloid
leukemia: Determination of prognostic significance of rare
recurring chromosomal abnormalities among 5876 younger adult
patients treated in the United Kingdom Medical Research Council
trials. Blood. 116:354–365. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Röllig C, Bornhäuser M, Thiede C, Taube F,
Kramer M, Mohr B, Aulitzky W, Bodenstein H, Tischler HJ, Stuhlmann
R, et al: Long-term prognosis of acute myeloid leukemia according
to the new genetic risk classification of the European LeukemiaNet
recommendations: Evaluation of the proposed reporting system. J
Clin Oncol. 29:2758–2765. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McGowan-Jordan J, Simons A and Schmid M:
An International System for Human Cytogenomic Nomenclature (2016).
Cytogenetic and Genome Research. 149:1–2. 2016.
|
|
41
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bhan A and Mandal SS: lncRNA HOTAIR: A
master regulator of chromatin dynamics and cancer. Biochim Biophys
Acta. 1856:151–164. 2015.PubMed/NCBI
|
|
44
|
Sun J, Cheng L, Shi H, Zhang Z, Zhao H,
Wang Z and Zhou M: A potential panel of six-long non-coding RNA
signature to improve survival prediction of diffuse large-B-cell
lymphoma. Sci Rep. 6:278422016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schlenk RF, Dohner K, Krauter J, Fröhling
S, Corbacioglu A, Bullinger L, Habdank M, Späth D, Morgan M, Benner
A, et al: Mutations and treatment outcome in cytogenetically normal
acute myeloid leukemia. N Engl J Med. 358:1909–1918. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu Y, Sun Y, Shen H, Ding L, Yang Z, Qiu
H, Sun A, Chen S and Wu D: Allogeneic hematopoietic stem cell
transplantation could improve survival of cytogenetically normal
adult acute myeloid leukemia patients with DNMT3A mutations. Am J
Hematol. 90:992–997. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dombret H and Gardin C: An update of
current treatments for adult acute myeloid leukemia. Blood.
127:53–61. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Vandewalle C, Van Roy F and Berx G: The
role of the ZEB family of transcription factors in development and
disease. Cell Mol Life Sci. 66:773–787. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hill L, Browne G and Tulchinsky E:
ZEB/miR-200 feedback loop: At the crossroads of signal transduction
in cancer. Int J Cancer. 132:745–754. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sánchez-Tilló E, Fanlo L, Siles L,
Montes-Moreno S, Moros A, Chiva-Blanch G, Estruch R, Martinez A,
Colomer D, Győrffy B, et al: The EMT activator ZEB1 promotes tumor
growth and determines differential response to chemotherapy in
mantle cell lymphoma. Cell Death Differ. 21:247–257. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wu Y, Lyu H, Liu H, Shi X, Song Y and Liu
B: Downregulation of the long noncoding RNA GAS5-AS1 contributes to
tumor metastasis in non-small cell lung cancer. Sci Rep.
6:310932016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Torkildsen S, Gorunova L, Beiske K,
Tjonnfjord GE, Heim S and Panagopoulos I: Novel ZEB2-BCL11B fusion
gene identified by RNA-sequencing in acute myeloid leukemia with
t(2;14)(q22;q32). PLoS One. 10:e01327362015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Schmalhofer O, Brabletz S and Brabletz T:
E-cadherin, beta-catenin, and ZEB1 in malignant progression of
cancer. Cancer Metastasis Rev. 28:151–166. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Stein EM and Tallman MS: Mixed lineage
rearranged leukaemia: Pathogenesis and targeting DOT1L. Curr Opin
Hematol. 22:92–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
